Brief: Astrazeneca Pharma India Terminates Distribution Agreement For Dapagliflozin With Abbott Healthcare
28/05/2021 09:39
May 28 (Reuters) - Astrazeneca Pharma India ASTR.NS :
* TERMINATION OF DISTRIBUTION AGREEMENT FOR DAPAGLIFLOZIN
BETWEEN
CO, ABBOTT HEALTHCARE
Source text for Eikon: ID:nBSE1gjy9B
Further company coverage: ASTR.NS ABOT.NS ABT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication